oncogenesis and tumor biology: targeting ascl1 · 2018. 5. 8. · oncogenesis and tumor biology:...

19
Oncogenesis and Tumor Biology: Targeting ASCL1 Rahul Kollipara Trisha Savage Karine Pozo Demetra Kelenis U01 CA213338-01 Developing ASCL1 and NEUROD1 Lineage Oncogene Targeted Therapy for Small Cell Lung Cancer (PI: Minna) Jane Johnson Lab Svetlana Earnest Pearl Wichaidit Courtney Powell Melanie Cobb Lab John Minna Lab Aiden Nguyen Luc Girard Kenneth Huffman Michael Peyton Adi Gazdar Lab Victor Stastny

Upload: others

Post on 02-Apr-2021

2 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Oncogenesis and Tumor Biology: Targeting ASCL1 · 2018. 5. 8. · Oncogenesis and Tumor Biology: Targeting ASCL1. Rahul Kollipara. Trisha Savage. Karine. Pozo. Demetra. Kelenis. U01

Oncogenesis and Tumor Biology: Targeting ASCL1

Rahul KolliparaTrisha Savage

KarinePozo

DemetraKelenis

U01 CA213338-01 Developing ASCL1 and NEUROD1 Lineage Oncogene Targeted Therapy

for Small Cell Lung Cancer (PI: Minna)

Jane JohnsonLab

Svetlana EarnestPearl Wichaidit

CourtneyPowell

Melanie CobbLab

John MinnaLab

AidenNguyen

Luc Girard

Kenneth HuffmanMichael Peyton

Adi GazdarLab

Victor Stastny

Page 2: Oncogenesis and Tumor Biology: Targeting ASCL1 · 2018. 5. 8. · Oncogenesis and Tumor Biology: Targeting ASCL1. Rahul Kollipara. Trisha Savage. Karine. Pozo. Demetra. Kelenis. U01

Major Goal:

To systematically classify SCLCs for their dependency on two key lineage oncogenes, ASCL1 and NeuroD1, and develop therapy targeted at these two transcription factors and their key downstream druggable targets.

U01 CA213338-01 Developing ASCL1 and NEUROD1 Lineage

Oncogene Targeted Therapy for Small Cell Lung Cancer (PI: Minna)

Page 3: Oncogenesis and Tumor Biology: Targeting ASCL1 · 2018. 5. 8. · Oncogenesis and Tumor Biology: Targeting ASCL1. Rahul Kollipara. Trisha Savage. Karine. Pozo. Demetra. Kelenis. U01

Updating Findings on Lineage Oncogenes ASCL1 and NEUROD1 in

SCLC

Testing ASCL1 and NEUROD1 targets in SCLC cells and xenografts

Identifying a group of transcription factors that cross and auto-regulate one another; testing their requirement for SCLC.

Identifying ASCL1 interacting proteins (co-factors)

Probing the role of ERK and the ERK-ASCL1 axis in SCLC

Page 4: Oncogenesis and Tumor Biology: Targeting ASCL1 · 2018. 5. 8. · Oncogenesis and Tumor Biology: Targeting ASCL1. Rahul Kollipara. Trisha Savage. Karine. Pozo. Demetra. Kelenis. U01

ASCL1 and NEUROD1 are lineage-specific bHLH transcription factors

• They are transcriptional activators.

• They, or their transcriptional targets, may provide unique, druggable, vulnerabilities in SCLC.

• They are required in multiple neuronal and neuroendocrine lineages during normal development.

• They are not mutated in SCLC but represent lineage-specific TFs required for tumor cell survival.

NEUROD1

ASCL1

ASCL1

NEUROD1

gene

Ascl1-/-

Page 5: Oncogenesis and Tumor Biology: Targeting ASCL1 · 2018. 5. 8. · Oncogenesis and Tumor Biology: Targeting ASCL1. Rahul Kollipara. Trisha Savage. Karine. Pozo. Demetra. Kelenis. U01

Understanding ASCL1 function in SCLC: New Biomarkers and New Targets

ASCL1 ASCL1

P

PP

Cofactors Regulators

Effectors

SCLC growth

PP

Page 6: Oncogenesis and Tumor Biology: Targeting ASCL1 · 2018. 5. 8. · Oncogenesis and Tumor Biology: Targeting ASCL1. Rahul Kollipara. Trisha Savage. Karine. Pozo. Demetra. Kelenis. U01

Identifying downstream transcriptional targets of ASCL1 and

NEUROD1 in SCLCDifferentially expressed genes in ASCL1HI and

NEUROD1Hi SCLC models

Potential Targets

ASCL1 or NEUROD1 ChIP-Seq

Associated genes

49394

NEUROD1Targets

571ASCL1 Targets

• Some shared, most distinctBorromeo et al. 2016

In Progress:Drop out screen in SCLC cell lines and in xenografts using an shRNA library with a subset of these targets.

Page 7: Oncogenesis and Tumor Biology: Targeting ASCL1 · 2018. 5. 8. · Oncogenesis and Tumor Biology: Targeting ASCL1. Rahul Kollipara. Trisha Savage. Karine. Pozo. Demetra. Kelenis. U01

Understanding ASCL1 function in SCLC: New Biomarkers and New Targets

ASCL1 ASCL1

P

PP

Cofactors Regulators

Effectors

SCLC growth

PP

Page 8: Oncogenesis and Tumor Biology: Targeting ASCL1 · 2018. 5. 8. · Oncogenesis and Tumor Biology: Targeting ASCL1. Rahul Kollipara. Trisha Savage. Karine. Pozo. Demetra. Kelenis. U01

Borromeo et al. 2016

******

Super-enhancers are associated with key cell

lineage genes

A core TF network may co-regulate genes important for tumor biology

Page 9: Oncogenesis and Tumor Biology: Targeting ASCL1 · 2018. 5. 8. · Oncogenesis and Tumor Biology: Targeting ASCL1. Rahul Kollipara. Trisha Savage. Karine. Pozo. Demetra. Kelenis. U01

ASCL1

NFIB

FOXA2

CANCER GENETARGETS

MYCL

NKX2.1Tumor growth

Is the function of each transcription factor interdependent and necessary for tumorigenesis?

A core TF network may co-regulate genes important for tumor biology

Page 10: Oncogenesis and Tumor Biology: Targeting ASCL1 · 2018. 5. 8. · Oncogenesis and Tumor Biology: Targeting ASCL1. Rahul Kollipara. Trisha Savage. Karine. Pozo. Demetra. Kelenis. U01

ASCL1 and FOXA2 bind many of the same sites in a SCLC cell line

Johnson Lab, unpublished

ASCL1/FOXA2 bound sites

?

Is each transcription factor interdependent and necessary for tumorigenesis?

Page 11: Oncogenesis and Tumor Biology: Targeting ASCL1 · 2018. 5. 8. · Oncogenesis and Tumor Biology: Targeting ASCL1. Rahul Kollipara. Trisha Savage. Karine. Pozo. Demetra. Kelenis. U01

ASCL1NFIB

FOXA2NKX2.1

H2107 ASCL1high SCLC cells48 hrs post treatment

Regulatory interactions between a subset of the core TF network

Karine Pozo

Page 12: Oncogenesis and Tumor Biology: Targeting ASCL1 · 2018. 5. 8. · Oncogenesis and Tumor Biology: Targeting ASCL1. Rahul Kollipara. Trisha Savage. Karine. Pozo. Demetra. Kelenis. U01

0

0.2

0.4

0.6

0.8

1

1.2

1.4

1.6

Cel

l sur

viva

l

siRNA

Kd-8

0%

Kd-9

5%

Kd-9

5%

ASCL1 loss is detrimental to SCLC survival

H2107 ASCL1high SCLC cells48 hrs post treatment

Karine Pozo

Page 13: Oncogenesis and Tumor Biology: Targeting ASCL1 · 2018. 5. 8. · Oncogenesis and Tumor Biology: Targeting ASCL1. Rahul Kollipara. Trisha Savage. Karine. Pozo. Demetra. Kelenis. U01

ASCL1

NFIB

FOXA2

CANCER GENETARGETS

MYCL

NKX2.1Tumor

survival

A core TF network may co-regulate genes important for tumor biology

Page 14: Oncogenesis and Tumor Biology: Targeting ASCL1 · 2018. 5. 8. · Oncogenesis and Tumor Biology: Targeting ASCL1. Rahul Kollipara. Trisha Savage. Karine. Pozo. Demetra. Kelenis. U01

Identifying ASCL1-cofactors in SCLC

Co-IP Mass Spec from SCLC (H2107)ASCL1

IPIgGIP Nuc Cyto

ASCL1

247 interactors

E12/E47HEBE2.2

Karine PozoMcGovern et al., 2010

ASCL1/PROX1

E15.5 mouselung

NKX2.1PROX1TRIM28CDK2

Page 15: Oncogenesis and Tumor Biology: Targeting ASCL1 · 2018. 5. 8. · Oncogenesis and Tumor Biology: Targeting ASCL1. Rahul Kollipara. Trisha Savage. Karine. Pozo. Demetra. Kelenis. U01

Understanding ASCL1 function in SCLC: New Biomarkers and Targets

ASCL1 ASCL1

P

PP

Cofactors Regulators

Effectors

SCLC growth

PP

Page 16: Oncogenesis and Tumor Biology: Targeting ASCL1 · 2018. 5. 8. · Oncogenesis and Tumor Biology: Targeting ASCL1. Rahul Kollipara. Trisha Savage. Karine. Pozo. Demetra. Kelenis. U01

ERK1/2

MEK1/2

SCLC

Growth Factors

ERK in SCLC and an ERK:ASCL1 Axis

• SCLC express relatively low levels of phosphoERK

• SCLC cells (ie H82 and H889) are insensitive to MEK inhibitors

Melanie Cobb Lab

Page 17: Oncogenesis and Tumor Biology: Targeting ASCL1 · 2018. 5. 8. · Oncogenesis and Tumor Biology: Targeting ASCL1. Rahul Kollipara. Trisha Savage. Karine. Pozo. Demetra. Kelenis. U01

H889

WB: ASCL1

Control +AP + PP2A

ERK1/2

MEK1/2

SCLC

Growth Factors• ASCL1 is phosphorylated and

can be an ERK substrate

• DUSP6 is an ASCL1 targetDUSP6

ASCL1?

H889 H2107 H69 H82 H524 H526 H720

ASCL1

DUSP6

Total ERK

Earnest and Cobb; unpublished

ASCL1 Uses DUSP6 to Set the Amplitude of ERK Signaling

?

Page 18: Oncogenesis and Tumor Biology: Targeting ASCL1 · 2018. 5. 8. · Oncogenesis and Tumor Biology: Targeting ASCL1. Rahul Kollipara. Trisha Savage. Karine. Pozo. Demetra. Kelenis. U01

Ongoing studies on Lineage Oncogenes ASCL1 and NEUROD1 in

SCLC Testing ASCL1 and NEUROD1 targets in SCLC cells

and xenografts

Identified a TF network; testing requirements for SCLC.

Identified ASCL1 interacting proteins; testing how they modulate ASCL1 activity

Probing the role of ERK and the ERK-ASCL1 axis in SCLC

Page 19: Oncogenesis and Tumor Biology: Targeting ASCL1 · 2018. 5. 8. · Oncogenesis and Tumor Biology: Targeting ASCL1. Rahul Kollipara. Trisha Savage. Karine. Pozo. Demetra. Kelenis. U01

Acknowledgements

FundingNCI Lung Cancer Spore UTSW

CPRITNCI: U01

Johnson LabTrisha SavageMark BorromeoRahul KolliparaKarine PozoDemetra Kelenis

Melanie Cobb Svetlana EarnestPearl Wichaidit

John MinnaKenneth HuffmanMichael Peyton

Longshan LiAlex AugustynAiden Nguyen

Luc GirardAdi Gazdar

Victor Stastny